Automated Insulin Delivery Effects During Driving Among Older Adults with Type 1 Diabetes in a Randomized Trial
Authors' conclusion
First-generation AID reduces hyperglycemic driving among older drivers with T1D, without increasing hypoglycemia.
Study context
- Population
- Adults aged ≥60 years with T1D; Continuous glucose monitoring (CGM) used during driving1,894 trips
- Participants
- 8 adults
- Comparison
- First-generation closed-loop automated insulin delivery (AID) vs sensor-augmented pump therapy
Methodological detailscrossover
- Crossover
Primary result
As reported in the abstract
TIR >5.0-10.0 mmol/L during driving
P = 0.033
Further findings
Trips with any CGM >16.7 mmol/L · fewer with AID
P = 0.006
Safety
- Trips with CGM <3.9 mmol/L — Trips including CGM <3.9 mmol/L, all trips · no between-stage difference
- Three percent · P = 0.52
- System alerts — Trips with system alerts, all trips · no between-stage difference
- 10% · P = 0.078
Original publication
Automated Insulin Delivery Effects During Driving Among Older Adults with Type 1 Diabetes in a Randomized Trial. Diabetes Technol Ther. Published 2 December 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →